Evidence-based guides on GLP-1, GLP-3, peptide therapy, and metabolic medicine — written by our clinical team.
The GLP-1 telehealth market has exploded. With dozens of programs now competing for your attention, we cut through the noise — comparing pricing, medication options, clinical oversight, and what each platform doesn't tell you upfront. Thinnex comes out on top for a specific set of reasons you'll want to understand before you decide.
Read full guideGLP-3 (retatrutide) activates three receptor pathways simultaneously — GLP-1, GIP, and glucagon. Phase 2 trial data published in the NEJM showed 24.2% average body weight loss. Here's what that means, and why almost no one is talking about it yet.
Read articleBoth are GLP-1 receptor agonists. Both work. But they operate through different mechanisms and produce different clinical outcomes. If you're deciding between them, this breakdown gives you everything you need — science, side effects, cost, and who each one is best for.
Read comparisonBoard-certified providers. FDA-registered pharmacy. Flat-rate pricing. No insurance required.
See If I Qualify — Takes 5 Minutes →